To explore the potentials of allicin (an organosulfur compound) from garlic, a natural anti-oxidant, in inducing apoptosis in monocytes from patients of cervical cancer.
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Induction of Apoptosis in Cervical Cancer HeLa Cells by Curcumin, Involvement of Mitochondrial Pathway.
Mayank Singh
Department of Biochemistry, All India Institute of Medical Science, New Delhi HeLa cells were cultured in DMEM medium supplemented in 10% FBS in a humidified atmosphere of 95% air and 5% CO2 at 37ºC and were treated with 50 and 100ìM curcumin for 24 hrs. The expression of various apoptosis related genes Bcl-2, Bcl-xl, Bax, p53, p73, ERK, JNK, Ras, C Myc, Cox 2, Cyclin D1 and Hsp 70 was assessed by western blotting. Apoptosis was measured by flow cytometery. Effect of curcumin on hTERT was studied using PCR ELISA. Caspase -3 and -9 activity was measured using their respective synthetic substrates by fluorimetery.
Treatment of HeLa cells with 50ìM and 100ìM Curcumin resulted in 19.04% and 33.04% apoptosis after 24 hrs. Curcumin induced distinct down regulation of ERK and upregulation of JNK. It induced the down regulation of p73 whereas p53 remained unchanged. A sustained increase in protein expression of proapoptotic Bax and simultaneous decrease in expression of antiapoptotic Bcl-xl and Bcl 2 was seen, This was accompanied by increase in activity of caspase -3 and -9. A decrease in expression of c Myc, Cox 2, Cyclin D1 and Hsp 70 was also observed. Distinct suppression in activity of human telomerase reverse transcriptase (hTERT) was obtained.
Curcumin mediated apoptosis in HeLa cells appears to be due to upregulation of proapoptic Bax and down regulation of antiapoptotic Bcl-2, Bcl XL accompanied by increase in Caspase -3 and -9 activity suggesting the role of mitochondria in curcumin mediated apoptotic cell death. Curcumin act as an antiinflammatory and antiproliferative agent by causing down regulation of Cox 2 and Cyclin D1. It causes distinct inhibition of hTERT thereby reducing proliferation of cancer cells. Cathepsin L (hCATL), a lysosomal endopeptidase expressed in all tissues and cell types has been implicated in both physiological and pathological processes. Elevated expression of cathepsin L has been reported in a number of human tumors. Similarly the status of p53, a key regulator of cell cycle is also altered in tumors. Therefore, the present study was planned to investigate if there is any correlation between p53 status and human cathepsin L expression.
To address this issue, we assayed cathepsin L activity in two human glial cell lines namely U87 MG (wild type p53) and U373 MG (mutant p53) with different p53 status.
Our results revealed significantly higher activity of this protease in U87 MG cells as compared to U373 cells. These results were further confirmed by immunoprecipitation and Western blotting. Similarly estimation of cathepsin L mRNA levels in the two cell lines by real time PCR and slot blot analysis revealed a 2-3 fold increase in hCATL mRNA levels in U87 MG as compared to U373 cells.
To understand the molecular mechanism of the above mentioned difference in the cathepsin L levels in the two cell lines, and to ascertain if the observed difference in the hCATL mRNA and proteins exhibited by the two cell lines was due to differential transcription of hCATL gene, we transfected U87 MG and U373 cells with hCATL promoter reporter constructs. Assay of the Luciferase activity in the transfected cells clearly established significantly higher hCATL promoter activity in U87 MG cells. We used a skin fibroblast cell line (TRO 41 cells) in which level of wild type p53 can be modulated by treatment with tetracycline, to further establish that higher levels of cathepsin L in U87 MG cells were only due to its wild type p53 status.
Thus we conclude that wild type p53 upregulates cathepsin L expression in human glioblastoma cells.
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Cerebrospinal Fluid Lactate Dehydrogenase, Proteins and Electrolytes as Markers of Central Nervous System Involvement in Patients with Acute Lymphocytic Leukemia.
Indian Journal of Clinical Biochemistry, December 2007, Vol. 22 (Supl.) with acute lymphocytic leukemia (ALL). Currently available modalities have limited value in diagnosing CNS involvement in early stages of disease. Raised cerebrospinal fluid (CSF) total lactate dehydrogenase (LDH) levels can predict CNS involvement in patients with various neurological disorders including CNS leukemia. The current study evaluates CSF total LDH, proteins and electrolytes (Na+, K+ and Cl-) as markers of CNS involvement in patients with ALL.
The study was conducted in 23 consecutive freshly diagnosed patients of ALL without any previous CNS disease. Analysis of CSF was done for total LDH, proteins and electrolytes in all the patients before the start of chemotherapy and when the patients were in remission or six weeks after chemotherapy whichever was earlier. 23 age and sex matched controls were also studied to set the normal reference range. The results were analyzed statistically by Student 't' test and Coefficient of co-relation between CSF LDH and CSF protein in patients with raised CSF LDH at the time of presentation was also calculated CSF LDH was elevated in 4 out of 6 patients with signs and symptoms of CNS involvement and 3 of these patients also had increased CSF protein levels. 2 out of 17 patients who did not have signs and symptoms of CNS involvement had elevated both CSF LDH and CSF protein levels. The increased levels came down to normal reference range after chemotherapy except in one patient in whom CSF LDH remained high. However, no significant change in CSF electrolytes (Na+, K+ and Cl-) was noted in these patients both before and after chemotherapy.
Raised CSF LDH and protein levels may indicate CNS involvement and can be used as markers for evaluation of CNS involvement in patients with ALL.
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Studies on Circadian Periodicity of Plasma Lipid Peroxides and Antioxidant Enzymes in Cervical Cancer Sushma Singh 1 , Ranjana Singh 1 , Urmila Singh 1 , Seema Mehrotra 1 , Shweta Saxena 2 , S P Saxena 2 , R K Singh 40 patients with cervical cancer, 30 to 60 years of age and 30 age-matched clinically healthy subjects were synchronized for one week with diurnal activity from 06:00 to 22:00 and nocturnal rest. Breakfast was around 08:30, lunch around 13:30 and dinner around 20:30. Drugs known to affect the fre radical system and its rhythm were not taken. Blood and urinary samples were collected at 6-hourly intervals for 24 hours under standardized, presemably 24-hour synchronized conditions. Determinations included plasms and urinary lipid peroxides, in the form of malondialdehyde (MDA), urinary creatinine, blood superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) and glutathione reductase (GR). Biochemistry, December 2007, Vol. 22 (Supl.) A marked circadian variation was observed for each studied variable in each group by population-mean cosinor (P<0.01). In addition to their differences in overall mean value (MESOR), patients differed from healthy volunteers also in terms of their circadian pattern.
Indian Journal of Clinical
Mapping the broader time structure with age and multifrequency rhythm characteristics of antioxidants and prooxidants is needed for exploring their putative therapeutic role as markers for better chemotherapeutic application in cancer chronoprevention and management of the disease. Incidence of hepatobiliary carcinoma (CA) is increasing in recent years and the serum enzymes are under intensive research for their detection. The present study was planned to find the diagnostic significance of serum Alkaline phosphatase (ALP), Gamma glutamyl transpeptidase (GGT) and Leucine amino peptidase (LAP) in hepatobiliary CA.
P9.8

Serum Enzymes in Hepatobiliary Carcinoma
The study was done on 30 patients of hepatobiliary CA. These were compared with 50 age and sex matched controls. The study group included cases of liver metastasis, CA Gallbladder, CA Pancreas, Periampullary CA and CA Bile duct. Serum samples were analysed for ALP, GGT and LAP. The study group was further divided into icteric and non-icteric subgroups and the three enzymes were again analysed in both the subgroups.
In the study group, mean levels of serum ALP (786.3±465.05 IU/L), GGT (193.30±116 .73 IU/L) and LAP (96.86 ± 34.74 IU/L) were found to be statistically significant (p<0.001) as compared to control group where the mean levels were 159.48±38.05 IU/L, 16.02±7.55 IU/L and 33.02±4.41 IU/L respectively. Further it was found that icteric subgroup had higher levels of ALP, GGT and LAP which were statistically significant (p<0.01) as compared to nonicteric subgroup. It was also found that serum LAP was the most frequently elevated enzyme (93.3%) in the study group followed by serum GGT and ALP which were raised in 83% and 73% cases respectively. Among icteric subgroup, serum ALP was elevated in all the cases (100%) followed by serum LAP and GGT in (92.8%) cases each. In nonicteric subgroup, serum LAP showed abnormal levels in maximum number of cases (93.7%) whereas serum GGT was raised in 75% followed by serum ALP in only 56.2% cases.
Serum ALP, GGT and LAP levels are significantly elevated in hepatobiliary carcinomas. Out of the three enzymes LAP has got high sensitivity in cases of hepatobiliary carcinoma and also in those patients where clinical jaundice has not appeared. We analyzed 100 cases of metastatic breast tumor specimens for studying the expression of tumor markers. HER-2/neu and ER/PR expression was analyzed by Immunohistochemistry and serum levels of Her-2/neu protein were measured by ELISA. Associations between HER-2/neu and ER/PR expression were analyzed using Spearman's correlation and the students 't' TEST.
HER-2/neu-positive tumors had significantly lower ER/PR expression than HER-2/neu-negative ones (P<0.001). HER-2/neu overexpression showed inverse correlation with ER/PR expression Hormone receptor expression is strongly related to response to hormone therapy in primary and advanced breast cancer. Reduced ER/PR expression may be one mechanism to explain the relative resistance of HER-2/neu-positive: hormone receptor positive tumors to hormone therapy.
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MTHFR C 677 T polymorphism and susceptibility to Acute Lymphoblastic Leukemia in children Single nucleotide polymorphisms (SNPs) have emerged as an important prognostic indicators for cancer chemotherapy. One such SNP is the methylenetetrahydrofolate reductase (MTHFR) gene. The MTHFR gene shows several polymorphisms and most studied one is C 677 T. This polymorphism has been shown to cause a 65% reduction in the in vitro activity of the enzyme in homozygous (T 677 T) and about 30% Indian Journal of Clinical Biochemistry, December 2007, Vol. 22 (Supl.) reduction in enzyme activity in heterozygous (C 677 T). Due to this there is decreased methyl THF for DNA methylation which could activate oncogenes or inactivate oncosupressor genes and could be a possible cause for cancers. On the other hand, decreased activity of MTHFR in polymorphic individuals leads to increased methylene THF levels. This reduces the misincorporation of uracil into DNA and thereby reducing the chances of DNA break and in turn reducing risk of certain cancers like colorectal cancer and acute lymphoblastic leukemia (ALL). Several case control studies have addressed variant forms of MTHFR gene altering the risk of leukemia. Till date there is no published data on C 677 T polymorphism and the role of this polymorphism in ALL in Indian population and hence the need for this study. 50 patients from the Paediatric Oncology Unit of our Institute, aged ¡Ü15years with a confirmed diagnosis of ALL, and prior to treatment formed the subject group. Control group comprised of 50 age and gender matched healthy children from among the patient's relatives. DNA was extracted from blood samples by phenol chloroform method. Genotyping was done by PCR/RFLP method of Friso etal. 50 samples of both controls and subjects were genotyped for C 677 T polymorphism and was seen in about 12% subjects and 15 % in controls.
Some more samples will be analysed to establish the role of C677T MTHFR polymorphism on susceptibility to ALL in children P9.11
Significance of sialyl Lewis-X and E-Cadherin in Oral Cancer and Oral Pracancers The alterations in sialyl Lewis-X (SLe X ), a cell surface antigen and E-cadherin, a cell adhesion molecule are reported to play a major role in various malignancies. Our study evluated significance of SLe X and Ecadherin in oral cancer. Both the markers were detected using western blot analysis from oral malignant (n=25), and oral precancerous tissues (OPC, n=20) and their adjacent normal tissues.
Significant alterations in the E-cadherin (E-cad) and SLe
X expression were observed in malignant and precancerous tissues. E-cad western blot revealed presence of two bands, a 120 kDa (native, E-cad 120 ) and a 97 kDa (truncated E-cad 97 ). Higher accumulation of SLe X and truncated E-cad 97 in malignant and OPC tissues as compared to their adjacent normal tissues was observed. Receiver's Operating Characteristics (ROC) curve analysis showed good discriminatory efficacy of SLeX, E-cad 97 and E-cad
97
: 120 radio between the malignant and adjacent normal tissues. Further, a positive corrleation of SLeX and E-cad 97 and overexpression with advanced stage of the disease and lymph node metastasis was observed. Our results documented that overexpresionof SLex and E-cad 97 in OPC tissues may be useful to predict metastatic potentials of tumors at an early stage of oral carcinogenesis. Also, the SLeX overexpression and E-cadherin truncation are early events which may facilitate the tumor metastasis. Alterations in glycosylation patterns have long been associated with malignant transformation and cancer progression. We investigated significance of linkage-specific sialylation changes in oral carcinogenesis. Tissue and serum levels of total sialic acid (TSA), linkage-specific sialyltransferases (ST) and sialoproteins were analyzed from patients with oral precancerouus conditions (OPC) and oral cancer as well as the post-treatment follow-up blood samples of oral cancer patients. TSA levels were measured using spectrophometric method. The linkage-specific lectins Sambusus nigra (SNA) and Maackia amurensis (MAL) specific for α2,6-and α2,3-linked sialic acid respectively, were used to analyze ST activity and sialoproteins. Malignant tissues showed significantly higher levels of TSA, reactivity of SNA and MAL, and α2,3-ST activity as compared to the adjacent normal tissues. α2, 6-ST was also higher in malignant tissues. Similarly, the marker levels were higher in precancerous tissues than their matched pairs. Serum levels of TSA, TSA/ total proteins, α2,6-sialoproteins and α2,6-ST were markedly increased in untreated oral cancer patients compared to the controls and OPC as well as responder patients. Serum levels of the markers were higher or comparable between untreted oral cancer patients and non-respondents. Serum levels of α2,3 -sialylation were elecated in non-responders compared with the responders. Further, the observed variation in marker levels in tissue and serum were found to be associated with various histopathologic features and disease progression. Thus, the data suggest potential utility of sialylation markers in early detection, prognostication and treatment monitoring of oral cancer.
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Differential Expression of Total and Free Prostate Breast Diseases
Prostate Specific Antigen (PSA), an established marker of prostatic diseases in men was considered to be absent in females but various studies have revealed cyclical generation of PSA in females with a peak following the progesterone peak during the menstrual cycle. PSA exists in two forms in the serum mainly PSA-ACT and free PSA.PSA is suggested to be a good diagnostic and prognostic marker of malignant breast diseases by many researchers. This study was conducted with an objective to find out the predominant circulatory form of PSA in various study groups and their diagnostic and prognostic significance .
34 malignant and 20 benign breast disease cases were selected along with 33 healthy controls. TPSA and FPSA were estimated by chemiluminescence and Serum Testosterone by ELISA. 10 malignant cases were reevaluated after 3 months of surgical removal of tumour mass. Biochemistry, December 2007, Vol. 22 (Supl.) Serum Testosterone was found to be raised in breast diseases reaching a statistically significant value (p<0.01).A direct relationship was observed between serum Testosterone and serum PSA (Spearman Rank Correlation coefficient 0.727). TPSA was raised in both benign and malignant breast diseases in comparison to controls(p< 0.01) but FPSA was significantly raised only in malignant breast diseases (p<0.05).FPSA was the predominant molecular form in malignant breast diseases whereas PSA-ACT was found to be predominant in benign cases and controls. Both TPSA and FPSA were significantly reduced after surgical removal of the malignant breast tumors (p<0.001).
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Our study revealed a positive association of serum Testosterone and serum PSA in breast diseases indicating regulatory role of Testosterone on production of PSA. T PSA showed a higher sensitivity whereas FPSA revealed a very high specificity for malignant breast diseases. PSA shows promise to be used as a diagnostic and prognostic marker for malignant breast diseases.
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To determine clinical significance of Metastasis Tumor Antigen (MTA1) expression in Invasive Ductal Breast Carcinomas Chromatin remodeling pathways are critical in regulation of cancer related genes and are currently being explored as potential targets for therapeutic intervention. The metastasis tumor antigen (MTA) family of proteins, a group of 70 to 80 kDa polypeptides, has been shown to be functional components of the Mi-2/NuRD complex, a major macromolecular form of histone deacetylases which has been linked to transcriptional repression, cellular proliferation and cancer.
Paraffin embedded sections from primary breast tumors (IDCs) were immunostained with MTA1, ERƒÑ and PR antibodies.
Immunohistochemical analysis showed a marked increase of nuclear MTA1, both in percentage and intensity in IDCs. Intense MTA1 protein nuclear expression was observed in ER and PR negative carcinomas.
MTA1 over-expression is associated with tumor progression and it will be worthwhile to explore whether inhibition of MTA1 expression may be an effective strategy for therapeutic intervention in breast cancer progression. A significant decrease in Plasma Total Cholesterol, HDL and VLDL Cholesterol was observed in Oral Precancerous patients ( p < 0.05) as compared to the controls. Also a significant decrease in LDL and HDL Cholesterol was observed in patients of cancer as compared to the controls. The tobacco habituates showed lower plasma lipid levels than the non habituates. Our data strengthens the evidence of an inverse relationship between plasma lipid levels and head & neck cancer as well as oral precancerous conditions. The findings strongly suggest that there is an association between the lower level in plasma lipid profile in oral cancer, oral precancerous conditions, and with the habit of tobacco consumption. However, such associations were found to be more significant in case of oral precancerous conditions.
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Expression of Survivin, BCL-2, BAX and P53 Oral cancer, an insidious devastating malignancy, comprises 90% of the total cancer incidence in India.
In this study, we investigated the tissue expression of survivin, Bcl-2, Bax and p53 in the buccal mucosa of the oral cavity.
Paraffin-embedded tissue samples from 38 patients with primary oral sqamous cell carcinoma (OSCC)
Indian Journal of Clinical Biochemistry, December 2007, Vol. 22 (Supl.) and 17 patients with leukoplakia were used. The expression of survivin, Bcl-2, Bax and p53 was evaluated using immunohistochemical-staining method.
The immunoreactivities for survivin, Bcl-2 and Bax increased in the transition from precancerous lesions to high-grade carcinomas. There was a significant increase in survivin expression (P<0.001) with increasing grade of malignancy. Fourteen lesions from 38 patients were found to be positive for nuclear p53 staining while none of the precancerous lesions showed p53 positivity.
These results suggest that survivin may play an important role to apoptosis resistance in response to therapy.
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Lipid Profile and Blood Glucose Levels in Breast Cancer Patients
Carcinoma of the female breast is the most common cause of cancer of females in developed countries. In India, it is second only to carcinoma cervix. Lower levels of Total cholesterol (TC), HDL-C and LDL-C and higher levels of TG, VLDL-C and Blood glucose are associated with breast cancer.
The present study included 50 diagnosed cases of breast cancer compared to 50 age matched healthy control women. The main investigations caried out were (1) serum TC estimated by CHOD-POD method.
(2) Serum HDL-C estimated by phosphotugnstate/Mg2+ precipitation method. The serum TC; serum HDL-C; serum LDL-C were decreased significantly in the breast cancer patients as compared to healthy controls. The serum TG & serum VLDL-C were significantly increased in breast cancer patients. The blod glucose levels were higher in the breast cancer patients (though not significant statistically).
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Detection of Polymorphic CYP1B1 Variants in Delhi Population. Blood samples were collected from 68 donors from the blood bank at GTB Hospital and DNA was isolated by Miller's salting out method. Allele-specific PCR method was used for analysis of three known SNPs in the human CYP1B1 gene leading to an amino acid change, namely CYP1B1 *3, *4 and *5 alleles.
Frequency of CYP1B1 *3, *4 and *5 SNPs were found to be 4.4%, 8.8% and 11.76%(3,6 and 8 mutants in 68 cases) respectively.
CYP1B1 is an extra hepatic enzyme of potential importance for the metabolism of estrogen and metabolic activation of environmental carcinogens including organochlorine pesticides like lindane, DDT etc. Polymorphisms in this gene, together with increased environmental exposure may modify the metabolism of these compounds and affect the interindividual risk of development of various cancers such as cancer of skin, breast, testis, endometrium and brain etc. Detection of total polymorphism in CYP 1B1 gene in 2 5 % of the samples analyzed in the present study is a cause for concern keeping in view the environmental exposure to wide array of toxic compounds.
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Potential Clinical Utility of Serum HER-2/NEU Oncoprotein Concentrations in Patients with Breast Cancer .
Girija Ramaswamy
Dept. of Biochemistry, Kidwai Memorial Institute of Oncology, Bangalore
In breast cancer the Her-2/neu gene is amplified in 25-30% of all cases. The mechanism by which the amplification / overexpression is completely unknown. This molecular alteration is associated with a poor clinical prognosis in early stage breast cancer. The objective is to study serum Her-2/neu overexpression in our population, to compare the levels with other prognostic factors, to find the treatment response in Her-2/neu overexpressed patients and to study telomerase expression in breast cancer patients.
Serum Her-2/neu levels were studied in untreated consecutive 268 female patients with breast cancer and 175 age matched healthy female controls. The patients were selected from breast cancer and 175 age matched healthy female controls. The patients were selected from breast service unit of Kidwai Memorial Institute of Oncology. Serum Her-2/neu , CEA and CA 15.3 levels were measured by enzyme immunoassays. Clinical data, such as patient's age, menopausal status, stage, node, tumor size and hormone receptor status were available for statistical analysis. Tissue telomerase activities for 75 patients were studied by PCR-EIA in tumor samples and adjacent normal tissues. Serum Her-2/neu was overexpressed higher in pre menopausal patients with an age group of 41-50 Indian Journal of Clinical Biochemistry, December 2007, Vol. 22 (Supl.) years. Serum Her-2/neu was significantly increased in patients with positive nodes. Serum Her-2/neu was positively associated with higher tumor grade but inversely associated with hormone receptor status. There was a small but significant correlation between serum Her-2/neu and telomerase activity.
Her-2/neu serum test should be performed more frequently in young women with breast cancer and in estrogen receptor positive patients, to suggest modifications in systemic adjuvant therapy, including possibly the use of Herceptin. The PCR-EIA method offers a rapid, quantitative, nonisotopic assay for the determination of telomerase activity. Certain signal transduction pathways (Akt) mediated by Her-2/neu receptor activates association of telomerase component. This concept may help to develop drugs for inhibition.
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Promoter Hypermethylation of GSTP1, ERƒÑ and PR in serum and tumor DNA of Invasive Ductal Breast Carcinoma Patients Breast cancer is fast emerging as a leading cancer amongst females. DNA hypermethylation of gene promoter sequences are extremely promising cancer markers; their use for risk assessment, early diagnosis or prognosis depends on the timing of this gene change during tumor progression.
Epigenetic alterations affecting GSTP1, ERƒÑ and PR genes were analyzed in serum DNA and corresponding tumor DNA from breast cancer patients by Methylation Specific PCR (MSP) and Paraffin embedded sections from primary breast tumors (IDCs) were immunostained with ERƒÑ and PR antibodies.
Methylation frequencies ranged from 22% GSTP1 to 63% ERƒÑ . There was concordance between methylation in tumor and serum of each gene. Immunohistochemical analysis showed 55% and 51% loss of ERƒÑ and PR. Comparison of methylation data with immunohistochemical results showed that tumors harboring promoter methylation showed loss or reduced expression of the protein.
This study underscores the potential utility of DNA methylation based screening of serum as a surrogate for tumor DNA methylation as a tool for early detection of breast cancer. Further studies in this direction involving larger patient base and gene panel may improve the prognostic significance of circulating tumor DNA in breast cancer management. Prostate cancer is the leading cancer in older men. Serum-PSA assays revolutionized the early detection ,staging and management of prostate cancer. The main aim of this prospective study was to evaluate serum-PSA a pre-clinical screening test for carcinoma prostate in patients who had been referred with symptoms of bladder outflow obstruction.
This study was conducted on 85 patients over 50 years of age who visited Urology-OPD with symptoms of bladder outflow obstruction. Sr.PSA was advised to all of them along with Transrectal Ultrasonography (TRUS). Along with above case 20 age matched normal controls were also studied for PSA.
In this present study we have taken Sr.PSA cut-off value of 4.0 ng/ml, accordingly 61 patients has PSA value below 4.0 ng/ml and were diagnosed Benign prostatic hypertrophy(BPH). In 9 patients PSA value were borderline i.e 4.0 ng/ml -10.0 ng/ml, those were indeterminent cases; hence prostatic biopsy was advised and same was done by Urologist. But in 15 patients PSA values were more than 10.0 ng/ml for such patients diagnosis was made as carcinoma prostate after prostatic biopsy. according to the stage of tumor the treatment was given. The confirmed cases were followed up wherever possible. The results will be discussed later.
The application of screening in practice and healthcare policy can be adopted as it is cost effective and early detection regimens dramatically shift the stage at the time of detection toward locally confined diseases and while there is no debate that early aggressive treatment is the only way of curing prostate cancer.
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The Alterations in Lipid Profile in Squamous Cell Carcinoma of Oro-Pharyngeal Region Lipids are the major cell membrane components and they play an important role inthe biological functions like cell growth and division of the normal as well as malignant tissues. Many researchers have reported the association of plasma / serum lipids and lipoproteins in different types of cancers. However only few Indian Journal of Clinical Biochemistry, December 2007, Vol. 22 (Supl.) reports are available of lipid levels in squamous cel carcinoma of oro-phryngeal region which is one of the leading causes of mortality. The aim of this study was to investigate the alterations in the lipid profile in patients diagnosed with squamous cell carcinoma of orpharyngeal regin.
The serum lipid levels (Serum Cholesterol, LDL, HDL and VLDL cholesterol levels) cases diagnosed with squamous cell carcinoma of oro-pharyngeal region were estimated. In total, eight hundered subjects were studied (n = 800), out of which five hundred (n = 500) cases were of squamous cell carcinoma of orpharyngeal region and three hundered (n = 300) cases were of controls.
A statistically significant decrease was found in the mean serum cholesterol, low density lipoprotein, very low density lipoproteins and triglycerides in squamous cell carcinoma of oro-pharyngeal region, however, the mean of high density lipoproteins were higher.
The decreased level of total serum cholesterol, low density lipoprotein, very low density lipoproteins and triglycerides in squamous cell carcinoma of oro-pharyngeal region may be due to acute phae response attributed to the release of cytokines by tumor cells and the increase in high density lipoproteins in our study may be due to the altered functioning in lipoproteins lipase. The definition of a tumor marker has evolved considerably over the past two decades, principally as a result of advances in technology and redefinition by federal regulatory agencies. These markers have been used to supplement clinical findings and other diagnostic procedures, which hold great promise for management of patients care. So are the tumour markers permit as stand alone in the diagnosis for cancer patients? Although some heterogeneity occurs with each tumor marker and its associated malignancy, they provide clinically useful information when positive, and may be incorporated into management and monitoring of cancer patients.
There are many instances where blood tumor antigens such as CA 15-3 and CEA are elevated in approximately 80% of patients when they present with symptomatic metastatic disease. Despite clinical indications for the diagnosis and monitoring of metastatic breast cancer, blood tumor antigens are of no value in screening and early detection of primary disease. A similar case like AFP and LDH in hepato-cellular carcinoma and AFP and beta-hCG intesticular cancer. Also, bone scans are probably not necessary in prostate cancer patients with PSA levels <20 ng/ml.
The measurement of tumor markers in serum must be integrated with other technical advances in laboratory that relate to similar clinical questions. The important improvements and availability of new radiologi-Indian Journal of Clinical Biochemistry, December 2007, Vol. 22 (Supl.) cal imaging methods are also used in initial diagnosis and detection of recurrent or metastatic disease. The optimal use of markers should also ensure reduced costs, optimal patient outcomes as well as the ability to generate more data on emerging tumor markers so that progress is not impeded So, tumor markers have not been useful in screening because of lack of specificity, but are a useful adjunct in predicting recurrence and assessing efficacy of treatment.
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Preferential Recognition of 4-OHE2-NO-DNA by Cancer Autoantibodies Catechol estrogens, such as 4-hydroxyestradiol (4-OHE2) have been implicated in human carcinogenesis, although their mechanism of action has not been completely elucidated. It is known that catechol estrogens cause DNA damage through quinone-semiquinone redox cycling leading to free radical generation. Further, increased activity of inducible and constitutive NO synthase has been detected in various human tumors pointing towards the involvement of nitric oxide. Present study analyses the synergistic damaging effect of catechol estrogen and nitric oxide on DNA molecule eliciting autoantibodies in cancer patients.
Native plasmid DNA was modified by incubating pUC-18 DNA (0.152 mM bp) in 100 mM sodium phosphate buffer pH 7.4, containing 1.01 mM diethylenetriamine pentacetic acid (DTPA) with 0.505 mM 4-OHE2 and 1.01 mM SNP at 37º C for 2 hr. Modified DNA was characterized by UV and fluorescence spectroscopy, nuclease S1 digestion, restriction analyses, thermal denaturation etc. Antibodies against 4-OHE2-NO-DNA were induced in rabbits. DNA from cancer patients and healthy subjects was isolated from lymphocytes through an established procedure. Immunoglobulin G was isolated on Protein A-Agarose column.
Chemical alterations induced in plasmid DNA following exposure to 4-OHE2-NO include 26.9% hyperchromicity, generation of single strand breaks, damage to the restriction sites, modification of bases, decrease in Tm and change in the ellipticity of DNA. The modified DNA was highly immunogenic eliciting high titer immunogen specific antibodies in rabbits. Circulating cancer autoantibodies showed higher recognition of 4-OHE2-NO-DNA as compared to the native form (p<0.001). Oxidative lesions in human genomic DNA were immunochemically detected using anti-4-OHE2-NO-DNA antibodies as a probe.
Preferential recognition of 4-OHE2-NO-DNA by cancer autoantibodies coupled with enhanced binding of induced antibodies to DNA isolated from cancer patients is indicative of the involvement of unique epitopes on the modified DNA in the induction of cancer autoantibodies. Cervical cancer is the second most common cancer in women worldwide. It develops from the preneoplastic cervical intraepithelial neoplasia (CIN). Host factors are critical in regulating tumor growth and cytokines which modulate immunological control may be of particular importance. Vascular endothelial growth factor (VEGF), an angiogenic marker plays a crucial role in the regulation of tumor growth and metastasis. To study this, we examined the significance of serum VEGF levels in Indian women with advanced cancer cervix, before and after neo-adjuvant chemoradiation and assessed the relevance of these levels to therapeutic response.
Sixty patients with advanced cancer cervix (FIGO IIIa-IVa) and 60 healthy controls were enrolled in this study and HPV status was determined. The samples were collected: before the start of therapy; after the second course of chemotherapy; two weeks after the completion of external and brachyradiation and after 1 year on follow-up studies. VEGF estimations were done by ELISA. Response to therapy was assessed during and after therapy and after one year of follow-up.
Pre-treatment levels of serum VEGF levels were significantly higher in patients with cervical carcinoma than in the healthy controls (p<0.000). After chemotherapy, a decrease in VEGF levels was observed in complete responders, as compared with partial/non-responders; which became highly significant after completion of therapy. The pre-treatment VEGF levels were significantly correlated (p < 0.000) with HPV status.
After sequential chemoradiotherapy, complete responders showed significant decrease in VEGF levels, which was sustained even after one year of completion of therapy. This important finding suggests that pretreatment VEGF levels and the extent of their change during treatment can predict the therapeutic response to neoadjuvant chemoradiation in advanced cancer cervix. The serum levels of VEGF have potential usefulness as biological markers of SCC of the uterine cervix. Detection of circulating tumor cells by molecular techniques has been shown to be useful in early diagnosis of various cancers resulting in better management strategies. Recurrence and metastases are a common occurrence in differentiated thyroid carcinoma hence life long monitoring of the patient is required.The aim of the study was to optimize Quantitative Real-Time RT-PCR of thyroglobulin (TG) as a molecular technique for detection of circulating tumor cells in thyroid cancer patients.
Total RNA was extracted from thyroid tissue using TRIzol and cDNA was prepared with random hexamer primers and M-MuLV reverse transcriptase. Serial dilutions of the cDNA (100ng -0.1pg) were used to establish the Real-Time PCR standard curves for glyceraldehyde 6 phosphate dehydrogenase (GAPDH) and TG genes using Syber Green I. The assay was used initially to determine the gene expression in sera of normal healthy controls.
Standard curves for GAPDH as well as for TG were successfully established. The efficiencies of amplification were 83.51 ± 3.89% and 85.66 ± 5.43% and the slope of the standard curves were -3.80 ± 0.14 and -3.73 ± 0.18 for GAPDH and TG respectively. The linearity of the standard curve was confirmed by R squared (R2) value which is Pearson Correlation coefficient. R2 values for GAPDH and TG were 0.97 ± 0.02 and 0.99 ± 0.03 respectively. The expression of both the genes was studied in normal controls. GAPDH expression was much more ( range: 20.94 -164.9 ng, median 86.39ng) as compared to the expression of TG gene range: (0.06 -1.14) x 10-4ng, median 0.33 x 10-4ng .
Quantitative Real -Time RT-PCR for GAPDH and TG genes was standardized. The standard curves obtained were linear, stable and reproducible. Real -Time RT-PCR was able to detect the specific GAPDH and TG transcripts in circulation in normal healthy individuals. It will further be useful for detection of micro-metastasis in thyroid cancer patients. VEGF (Vascular endothelial growth factor) is known to be a potent stimulator of angiogenesis and thereby contributes immensely to tumor growth. Cathepsin L is a cystein protease which plays an important role in intracellular protein degradation. Both cathepsin L and VEGF are over-expressed in several human tumors and promote angiogenesis, tumor cell viability and invasiveness. Since cathepsin L is known to be upregulated by various growth factors, we have studied the role of VEGF in regulating cathepsin L expression in U87MG cells (human glioblastoma), which are highly malignant. Transient transfection of U7MG cells with VEGF expression vector resulted in a significant increase in the synthesis and secretion of cathepsin L. These results were further corroborated by a parallel increase in the mRNA levels and promoter activity of cathepsin L by VEGF. By deletion analysis, we have further identified a 47 base pair VRE (VEGF response element) in the cathepsin L promoter. Site directed mutagenesis studies demonstrated that both SP-1 and AP-4 motifs present in this VRE region contribute to VEGF responsiveness. These results prove for the first time that over-expression of VEFG in human glioblastoma cells induces cathepsin L expression at the transcriptional level. This mechanism could be involved in the enhanced tumorogenic potential of these cells.
P9.28
Studies on Oxidants and Antioxidants status in patients with Chronic Myeloid Leukemia The neoplastic disorder multiple myeloma (MM) is a B-cell malignancy characterized by the accumulation of clonal population of plasma cells in the bone marrow that secrete monoclonal immunoglobulin protein.
Although radiaiton, environmental factors, virsues and other factors have been suggested as potential causes of the disease, the aetiopathogeneis of MM is obscure. It accounts for 1% and 10% of total cancer and hematological malignancies respectively. Reactive oxygen species and other free radicals are known to be the mediators of phenotypic and genotypic changes that lead from mutation to neoplasia in all cancers including multiple myeloma. The objective of the present work was to study the alterations in the enzymatic and non-enzymatic antioxidant levels in clinically confirmed cases of multiple myeloma (n=50) with observed elevated levels of â-2 microglobulin and results were compared with 50 healthy controls.
â-2 microglobulin levels were estimated by ELISA. The levels of enzymatic antioxidants; Superoxide dismutase (SOD) and glutathione peroxidase (GPS) were spectrophotomericaly estiamted in whole blood using commercially available RANDOX kits. The circulating status of Vitamin C and Vitamin E (nonenzymatic) was checked by standardized protocols using spectrophotometer and floorometer respectively.
The serum levels of â-2 microglobulin were signficantly higher (>3ug/mi) in multiple myeloma patients as compared to healthy controls. The circulating levels of SOD & GPX were found significantly decline (p<0.001 and 0.04 respectively) in patients. Similarly the serum levels of non-enzymatic antioxidants (Vitamin C & Vitamin E) were signficantly decreased (p<0.001 and 0.02 respectively) in the patient group as compared to healthy controls. On the other hand, an argument against using supplemental antioxidants during chemotherapy is that they may interfere with the oxidative breakdown of cellular DNA and cell membranes necessary for the agents to work.
To know the effect of complete antioxidant tablets on oxidant-antioxidant status in breast cancer patients receiving chemotherapy.
125 female breast cancer patients on chemotherapy (period varies 3-6 months) were randomly selected for this study ranging in age group 47±5 yrs. Patients were divided asGroup I-consists of 62 patients taking antioxidant supplementation for more then 3 months (I tablet per day) Group II-consists of 63 patients who were not on antioxidant supplementation Both the groups were evaluated for oxidant & antioxidant status by evaluating them for lipid peroxidation product MDA & antioxidant enzyme SOD & Catalase.
Breast cancer patients receiving chemotherapy without antioxidant supplementation showed increased level of MDA(4.7±0.9 n mol of MDA/ml)when compared with on treatment patients taking antioxidant tablets (3.9±0.6 n mol of MDA/ml) p<0. Human cathepsin L (ctsl) is encoded by at least five mRNA species having identical open reading frames and different 5 untranslated regions. All these mRNA variants encode the same primary polypeptide of 333 amino acids. In the present study we report that an unknown mRNA of human origin (Gene Bank accession number AF 217997) is a splice variant of human cathepsin L mRNA(hCATL A IVZ). It uses the ATG (nucleotide 247) present in the exon of 5 as translation initiation condon and therefore encodes a truncated form of cathepsin L (Δctsl) containing only 151 C-termina amino acids. Mouse fibroblasts transfected with hCATLA IV expression vector synthesized large amounts of Δctsl but unlike ctsl is was neither secreted into the medium nor it couldbe detected in the lysosomal compartment. However, Immunogold electron microscopy revealed its localization in the nucleus, cytosol and perinuclear region. Whereas ctsl requires prior activation, the in vitro translated and bacterially expressed ctsl exhibited anzyme activity against a cathepsin L specific synthetic substrate Z-Phe-ArgNMec without any prior activation. Heat stability studies revealed tha t ctsl retains approximatley 60% of its enzymes activity at 65 o C at least for an hour whereas recombinant ctsl completely lost its activity at 45 o C after 5 min. These finds were coroborated by the melting temperature (Tm) of ctsl which was calculated to be 72 o C from the spectroscopic melging curves. Similarly the secondary structure of the Δctsl remained unaltered at elevated temperatures unlike ctsl. Transient expression of ctsl in HepG2 cells resulted in cell death as indicated by MTT assay, propidium iodide staining and TUNEL assay. However, no such effect was observed in these cells after transfection with ctsl expression vector or empty vector. We propose that cytotoxic properties of Δctsl may be due to its altered sub-cellular localization, nd its ability to degrade protein(s) at neutral pH witout prior activation. Cathepsin L is a lysosomal cysteine protease responsible for the normal turnover of proteins. It has a significant role in a number of physiological processes and its altered expression has been observed in various pathological processes as well, for example, glomerulonephrits, rheumatoid arthritis, and muscular dystrophy. Its ability to efficiently degrade components of extracellular matrix makes it an indispensable tool for metastasis in cance.r Its secretion is increased in presence of growth factors, tumor protmers. The aim of the present study is identification of oncogene response element in the human cathepsin L promoter. For this purpose, normal human liver cells were stably transfected with oncognic ras. Cathepsin L activity when compared was higher in normal cells than in cells stably expressing ras (CLR).
The full-length promoter reporter construct when transiently transfected was activated in presence of ras. Similarly, cathepsin L mRNA expression was elevated in stable cells. The contradictory results obtained at translational and transcriptional levels were resolved by immunoflourescence, which indicates, altered localization of cathepsin L in presenc eof res. In the second part of the study the expression levels of cathepsin L in chronic myeloid leukemia was assessed and compared with that of normals. CML is caused by the expression of the p210 Bcr-Abl fusion protein which results from the Philadelphia translocation, t(9;22).
Our initial experiments indicate that this genomic instability might be contributing to an increased Cathepsin L activity in leukemia patients. Expression of Brc-Abl leads to activation of Ras and its interruption impairs bcr-abl transforming activity. We aim to find a significant correlation, if any, between ras activation and increased cathepsin L expression in leukemia.
